MAIA Biotechnology Inc.
2.19
-0.02 (-0.90%)
At close: Jan 15, 2025, 11:46 AM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -19.77M -15.77M -12.58M -6.96M -6.49M
Depreciation & Amortization n/a n/a n/a n/a n/a
Stock-Based Compensation 3.09M 2.32M 2.72M 3.89M 4.14M
Other Working Capital 2.46M 581.82K 320.23K 1.26M 164.63K
Other Non-Cash Items 526.53K 1.00M 4.61M -28.02K 4.55M
Deferred Income Tax n/a n/a n/a n/a n/a
Change in Working Capital 3.09M 793.16K 1.13M 1.25M 269.46K
Operating Cash Flow -13.07M -11.66M -4.12M -1.84M -1.57M
Capital Expenditures -4 n/a n/a n/a n/a
Acquisitions n/a n/a n/a n/a 187.56K
Purchase of Investments n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a 187.56K
Investing Cash Flow n/a n/a n/a n/a 187.56K
Debt Repayment n/a n/a 7.43M 668.87K 35.00K
Common Stock Repurchased n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a
Other Financial Acitivies -2.15M -1.50M 6.60M 79.19K 2.19M
Financial Cash Flow 9.27M 12.48M 14.03M 798.05K 2.22M
Net Cash Flow -3.80M 376.63K 9.91M -1.05M 1.71K
Free Cash Flow -13.07M -11.66M -4.12M -1.84M -1.57M